{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:20:33Z","timestamp":1788412833558,"version":"build-2803163510"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:p>Up-to-date melanoma relative survival (RS) estimates and trend analysis facilitate close monitoring of melanoma patients\u2019 prognosis. This study aimed to provide recent 5-year and 10-year RS from melanoma, stratified by prognostic factors, and identify latest survival trends. Data from 12 German cancer registries were analysed. We included patients with primary cutaneous malignant melanoma (ICD-10: C43.X) diagnosed in 1997\u20132013 who were at least 15 years old. Five-year and 10-year RS were estimated by period analysis. For 10-year RS analyses, we excluded patients who were 75 years of age or older. Analyses were stratified by sex, age, histology, tumour stage, and body site. We included 82 901 patients, of whom 51% were women. The median age at diagnosis was 62 years. Five-year and 10-year RS in 2007\u20132013 were 92.4 and 90.8%, respectively. RS was higher in women. The prognosis worsened with older age and higher stage. In superficial spreading melanoma and lentigo maligna melanoma, RS was high; it was lower in nodular, acral lentiginous and \u2018other\u2019 melanoma. RS was the highest for melanoma on the arms; RS for melanoma on unknown or overlapping sites of the skin was the lowest. Five-year and 10-year RS increased significantly from 2005\u20132007 and 2008\u20132010 to 2011\u20132013, by 3.5 and 3.3 percentage points, respectively. For melanoma of \u2018other\u2019 histology, 5-year and 10-year RS increased significantly. Ten-year RS also increased significantly in men with superficial spreading melanoma and T4 melanoma, and in women with T3 melanoma. Melanoma RS improved, especially in certain subgroups. The reasons for improvements need to be investigated further.<\/jats:p>","DOI":"10.1097\/cmr.0000000000000482","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T21:43:23Z","timestamp":1531777403000},"page":"386-395","source":"Crossref","is-referenced-by-count":14,"title":["Long-term relative survival from melanoma in Germany 1997\u20132013"],"prefix":"10.1097","volume":"30","author":[{"given":"Alicia","family":"Brunssen","sequence":"first","affiliation":[{"name":"Institute for Social Medicine and Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Jansen","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Eisemann","sequence":"additional","affiliation":[{"name":"Institute for Social Medicine and Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Waldmann","sequence":"additional","affiliation":[{"name":"Institute for Social Medicine and Epidemiology"},{"name":"Hamburg Cancer Registry, Ministry for Health and Consumer Protection, Hamburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janick","family":"Weberpals","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kraywinkel","sequence":"additional","affiliation":[{"name":"German Centre for Cancer Registry Data, Robert Koch Institute, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Eberle","sequence":"additional","affiliation":[{"name":"Cancer Registry of Bremen, Leibniz Institute for Prevention Research and Epidemiology \u2013 BIPS, Bremen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Holleczek","sequence":"additional","affiliation":[{"name":"Saarland Cancer Registry, Saarbruecken"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylke R.","family":"Zeissig","sequence":"additional","affiliation":[{"name":"Cancer Registry of Rhineland-Palatinate, Mainz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[{"name":"Division of Preventive Oncology, National Center for Tumor Diseases (NCT)"},{"name":"German Cancer Consortium (DKTK)"},{"name":"Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Katalinic","sequence":"additional","affiliation":[{"name":"Institute for Social Medicine and Epidemiology"},{"name":"Institute for Cancer Epidemiology, University of Luebeck, Luebeck"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"R3-20230902","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2133.2012.11039.x","article-title":"Up-to-date results on survival of patients with melanoma in Germany.","volume":"167","author":"Eisemann","year":"2012","journal-title":"Br J Dermatol"},{"key":"R4-20230902","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2230.2000.00692.x","article-title":"Malignant melanoma: clinical variants and prognostic indicators.","volume":"25","author":"MacKie","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"R5-20230902","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE-5 \u2013 a population-based study.","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"R6-20230902","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/ijc.29316","article-title":"Recent cancer survival in Germany: an analysis of common and less common cancers.","volume":"136","author":"Jansen","year":"2015","journal-title":"Int J Cancer"},{"key":"R9-20230902","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ijc.24344","article-title":"Implications of incomplete registration of deaths on long-term survival estimates from population-based cancer registries.","volume":"125","author":"Brenner","year":"2009","journal-title":"Int J Cancer"},{"key":"R10-20230902","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/1097-0142(19951115)76:10<1687::AID-CNCR2820761002>3.0.CO;2-I","article-title":"The relative survival rate.","volume":"76","author":"Henson","year":"1995","journal-title":"Cancer"},{"key":"R12-20230902","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/aje\/kwj243","article-title":"Up-to-date and precise estimates of cancer patient survival: model-based period analysis.","volume":"164","author":"Brenner","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R13-20230902","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#","article-title":"An alternative approach to monitoring cancer patient survival.","volume":"78","author":"Brenner","year":"1996","journal-title":"Cancer"},{"key":"R14-20230902","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardising survival ratios.","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur J Cancer"},{"key":"R15-20230902","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1055-9965.EPI-11-0697","article-title":"Deriving valid population-based cancer survival estimates in the presence of nonnegligible proportions of cancers notified by death certificates only.","volume":"20","author":"Brenner","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R16-20230902","first-page":"1","article-title":"Basic issues in estimating and comparing the survival of cancer patients.","volume":"132","author":"Berrino","year":"1995","journal-title":"IARC Sci Publ"},{"key":"R18-20230902","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ejca.2015.07.039","article-title":"Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study.","volume":"51","author":"Crocetti","year":"2015","journal-title":"Eur J Cancer"},{"key":"R19-20230902","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/annonc\/mdr131","article-title":"Survival from common and rare cancers in Germany in the early 21st century.","volume":"23","author":"Hiripi","year":"2012","journal-title":"Ann Oncol"},{"key":"R21-20230902","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/CEJ.0000000000000306","article-title":"Trends in net survival from skin malignant melanoma in six European Latin countries: results from the SUDCAN population-based study.","volume":"26","author":"Galceran","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"R22-20230902","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/annonc\/mdn639","article-title":"Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis.","volume":"20","author":"Gondos","year":"2009","journal-title":"Ann Oncol"},{"key":"R23-20230902","first-page":"19","article-title":"Differences in cancer survival in Canada by sex.","volume":"27","author":"Ellison","year":"2016","journal-title":"Health Rep"},{"key":"R24-20230902","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00403-015-1585-8","article-title":"Melanoma survival is superior in females across all tumour stages but is influenced by age.","volume":"307","author":"Khosrotehrani","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"R25-20230902","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2013.52.7564","article-title":"Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.","volume":"32","author":"Eriksson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R26-20230902","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.bjc.6603216","article-title":"Recent trends in cutaneous malignant melanoma in the Yorkshire region of England: incidence, mortality and survival in relation to stage of disease, 1993\u20132003.","volume":"95","author":"Downing","year":"2006","journal-title":"Br J Cancer"},{"key":"R27-20230902","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000216771.81362.6b","article-title":"Gender-related differences in outcome for melanoma patients.","volume":"243","author":"Scoggins","year":"2006","journal-title":"Ann Surg"},{"key":"R28-20230902","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cncr.23359","article-title":"Age and gender are significant independent predictors of survival in primary cutaneous melanoma.","volume":"112","author":"Lasithiotakis","year":"2008","journal-title":"Cancer"},{"key":"R29-20230902","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/annonc\/mdm498","article-title":"Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site.","volume":"19","author":"De Vries","year":"2008","journal-title":"Ann Oncol"},{"key":"R30-20230902","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1684\/ejd.2015.2557","article-title":"Survival advantage of women in localized melanoma mainly relies on clinical-pathological differences by sex. A retrospective study of 1,607 patients in Valencia, Spain.","volume":"25","author":"Kindem","year":"2015","journal-title":"Eur J Dermatol"},{"key":"R31-20230902","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2010.354","article-title":"Gender differences in melanoma survival: female patients have a decreased risk of metastasis.","volume":"131","author":"Joosse","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R32-20230902","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1097-0215(19981029)78:3<315::AID-IJC10>3.0.CO;2-5","article-title":"Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.","volume":"78","author":"Levi","year":"1998","journal-title":"Int J Cancer"},{"key":"R33-20230902","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/0-387-23962-6_5","article-title":"Age and co-morbidity in cancer patients: a population-based approach.","volume":"124","author":"Janssen-Heijnen","year":"2005","journal-title":"Cancer Treat Res"},{"key":"R34-20230902","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/bjd.12046","article-title":"Incidence and survival in patients with cutaneous malignant melanoma: experience in a U.K. population, 1984\u20132009.","volume":"168","author":"Hunter","year":"2013","journal-title":"Br J Dermatol"},{"key":"R35-20230902","doi-asserted-by":"crossref","first-page":"djv294","DOI":"10.1093\/jnci\/djv294","article-title":"Melanoma thickness and survival trends in the United States, 1989 to 2009.","volume":"108","author":"Shaikh","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R36-20230902","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/annonc\/mdm087","article-title":"Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands.","volume":"18","author":"De Vries","year":"2007","journal-title":"Ann Oncol"},{"key":"R38-20230902","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.1984.2.9.994","article-title":"Lentigo maligna melanoma has no better prognosis than other types of melanoma.","volume":"2","author":"Koh","year":"1984","journal-title":"J Clin Oncol"},{"key":"R40-20230902","first-page":"655","article-title":"Malignant melanoma in Ferrara, Northern Italy: epidemiologic survey focusing on tumor thickness.","volume":"150","author":"Borghi","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"key":"R41-20230902","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ijc.23495","article-title":"Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.","volume":"123","author":"Downing","year":"2008","journal-title":"Int J Cancer"},{"key":"R42-20230902","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/CMR.0000000000000245","article-title":"Superficial spreading melanoma: an analysis of 97 702 cases using the SEER database.","volume":"26","author":"Singh","year":"2016","journal-title":"Melanoma Res"},{"key":"R43-20230902","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/CMR.0000000000000394","article-title":"Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study.","volume":"28","author":"Uprety","year":"2017","journal-title":"Melanoma Res"},{"key":"R44-20230902","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2010.11.016","article-title":"Systematic skin cancer screening in Northern Germany.","volume":"66","author":"Breitbart","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R45-20230902","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1002\/cncr.27566","article-title":"Does skin cancer screening save lives? An observational study comparing trends in melanoma mortality in regions with and without screening.","volume":"118","author":"Katalinic","year":"2012","journal-title":"Cancer"},{"issue":"Suppl 3","key":"R47-20230902","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000364887","article-title":"Benefits and risks of skin cancer screening.","volume":"37","author":"Breitbart","year":"2014","journal-title":"Oncol Res Treat"},{"key":"R48-20230902","first-page":"629","article-title":"Skin cancer screening in Germany.","volume":"112","author":"Katalinic","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"R49-20230902","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ejca.2011.05.028","article-title":"Reduction of population-based cancer survival estimates by trace back of death certificate notifications: an empirical illustration.","volume":"48","author":"Holleczek","year":"2012","journal-title":"Eur J Cancer"},{"key":"R50-20230902","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejca.2015.10.059","article-title":"Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time.","volume":"52","author":"Brenner","year":"2016","journal-title":"Eur J Cancer"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T03:25:26Z","timestamp":1693625126000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000482","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,16]]}}}